Effects of Exergaming Session Frequency on Work Performance, Cognition, and Mobility in Adults Age 55 to 65

April 26, 2020 updated by: Tollár József, Somogy Megyei Kaposi Mór Teaching Hospital
Aim - determine the immediate and lasting effects of Exergaming frequency on work performance, health, motor, and cognitive function in clerical employees.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Hypothesis - In sedentary clerical workers the introduction of even 1 session / week exercise can cause lasting and correlated improvements in work, motor, and cognitive function, and effect which plateaus at 2 compared with 3 sessions / week. However, 6 months follow up would show residual effects only at the 3/week frequency in those who had become sedentary again.

Study Type

Interventional

Enrollment (Actual)

3

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Hungary
    • Somogy
      • Kaposvár, Somogy, Hungary, 7400
        • Somogy Megyei Kaposi Mór Oktató Kórház

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age
  • active worker
  • no detected neurological status

Exclusion Criteria:

  • Sever heart problem
  • Sever demeanor
  • Alkoholism
  • Drug problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exergame 3/week
The group does active training for 8 weeks after not training.
Other: Exergaming 3/week
virtual training 3 times a week(8 week-long)
Experimental: Exergame 2/week
The group does active training for 8 weeks after not training.
Other: Exergame 2/week
virtual training 2 times a week(8 week-long)
Experimental: Healthy control / Exergame 1/week
In the first 8 week-long only control group, The group will do 1 training/week for the next 8 weeks.
Other: Healthy control / Exergaming 1/week
In the first 8 week-long only control group. For the next 8 weeks, the control group will do 1 workout per week.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motor function
Time Frame: 8 weeks
Step test (as described by Prieske et al, motion and endurance test)
8 weeks
Motor Function
Time Frame: 8 weeks
Grip strength - Chair rise (as part of SPPB) the higher score better performance
8 weeks
MOBILITY
Time Frame: 8 weeks
-SPPB - the higher score better performance
8 weeks
BALANCE Functional reach
Time Frame: 8 weeks
Beam walking (4, 8, 12 cm 3 trials each, summed distance score) The longer the journey is, the better the performance
8 weeks
Cognitive function
Time Frame: 8 weeks
- MMSE (questionnaire…) the higher score better performance
8 weeks
Cognitive function
Time Frame: 8 weeks
- Processing speed: The Digit Symbol Substitution Test (DSST)
8 weeks
Mobility
Time Frame: 8 weeks
6MWT - The longer the journey is, the better the performance
8 weeks
Mobility
Time Frame: 8 weeks
Fast gait speed over 10 m - speed, the faster the better
8 weeks
Cognitive function
Time Frame: 8 weeks
Verbal and visual memory span and working memory (0-100 visual analog sclae-the higher score better performance)
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Somogy Megyei Kaposi Mór Teaching Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 15, 2018

Primary Completion (Actual)

January 15, 2019

Study Completion (Actual)

February 1, 2019

Study Registration Dates

First Submitted

November 6, 2018

First Submitted That Met QC Criteria

November 14, 2018

First Posted (Actual)

November 16, 2018

Study Record Updates

Last Update Posted (Actual)

April 28, 2020

Last Update Submitted That Met QC Criteria

April 26, 2020

Last Verified

November 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • IKEB009/2018

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe